Development and Internal Validation of a Prediction Model for Reversible Cognitive Frailty in People Living with HIV

BACKGROUND: Reversible cognitive frailty may be an important target for early identification among people with HIV (PWH). We developed a prediction model for reversible cognitive frailty and assessed its internal validity using clinical, laboratory, and medication-related data. SETTING: Positive Brain Health Now cohort, including adults recruited from five Canadian HIV clinics between 2013 and 2018. METHODS: Data from 824 adults with HIV aged 35 years or older were analysed. Reversible cognitive frailty was defined as co-occurring physical frailty and self-reported cognitive difficulty without dementia. Twenty candidate predictors were entered into least absolute shrinkage and selection operator logistic regression (LASSO) with 10-fold cross-validation to select the final predictor set. Internal validity was assessed through discrimination (apparent and optimism-corrected C-statistic via bootstrap resampling), calibration, and clinical utility (decision curve analysis). RESULTS: Reversible cognitive frailty was present in 7.5% of participants. The final model retained 10 predictors; the strongest were female sex, greater comorbidity burden, higher anxiety and depression scores, and higher anticholinergic medication burden, with additional contributions from hepatic, nutritional, HIV-related, and medication variables. On internal assessment, the model showed strong discrimination (optimism-corrected C-statistic 0.882), acceptable calibration, and net benefit over assess-all and assess-none strategies. At the optimal threshold, sensitivity was 91.9%, specificity 76.1%, and negative predictive value 99.1%. CONCLUSION: This is the first prediction model developed for reversible cognitive frailty in PWH, showing strong discrimination, acceptable calibration, and clinical utility within the development cohort. External validation in independent samples is needed before clinical use.

Authors

Institutions

Publication Details

Journal
JAIDS Journal of Acquired Immune Deficiency Syndromes
Published
2026-11-18
DOI
https://doi.org/10.1097/qai.0000000000004005
Primary Topic
HIV-related health complications and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Development and Internal Validation of a Prediction Model for Reversible Cognitive Frailty in People Living with HIV

Robyn M Tamblyn, Lesley K. Fellows, Henry Ukachukwu Michael, Nancy E. Mayo et al.
3 links
JAIDS Journal of Acquired Immune Deficiency Syndromes
HIV-related health complications and treatments
article

Development and Internal Validation of a Prediction Model for Reversible Cognitive Frailty in People Living with HIV

Robyn M Tamblyn, Lesley K. Fellows, Henry Ukachukwu Michael, Nancy E. Mayo, Marie‐Josée Brouillette
article en

Abstract

BACKGROUND: Reversible cognitive frailty may be an important target for early identification among people with HIV (PWH). We developed a prediction model for reversible cognitive frailty and assessed its internal validity using clinical, laboratory, and medication-related data. SETTING: Positive Brain Health Now cohort, including adults recruited from five Canadian HIV clinics between 2013 and 2018. METHODS: Data from 824 adults with HIV aged 35 years or older were analysed. Reversible cognitive frailty was defined as co-occurring physical frailty and self-reported cognitive difficulty without dementia. Twenty candidate predictors were entered into least absolute shrinkage and selection operator logistic regression (LASSO) with 10-fold cross-validation to select the final predictor set. Internal validity was assessed through discrimination (apparent and optimism-corrected C-statistic via bootstrap resampling), calibration, and clinical utility (decision curve analysis). RESULTS: Reversible cognitive frailty was present in 7.5% of participants. The final model retained 10 predictors; the strongest were female sex, greater comorbidity burden, higher anxiety and depression scores, and higher anticholinergic medication burden, with additional contributions from hepatic, nutritional, HIV-related, and medication variables. On internal assessment, the model showed strong discrimination (optimism-corrected C-statistic 0.882), acceptable calibration, and net benefit over assess-all and assess-none strategies. At the optimal threshold, sensitivity was 91.9%, specificity 76.1%, and negative predictive value 99.1%. CONCLUSION: This is the first prediction model developed for reversible cognitive frailty in PWH, showing strong discrimination, acceptable calibration, and clinical utility within the development cohort. External validation in independent samples is needed before clinical use.

JAIDS Journal of Acquired Immune Deficiency Syndromes
University of Calgary (CA), McGill University Health Centre (CA), Research Institute of the McGill University Health Centre (CA), O'Brien Institute for Public Health (CA), McGill University (CA)
Good health and well-being
HIV-related health complications and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon